患者与公众参与对临床试验招募和保留的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入26项研究,评估患者与公众参与(PPI)干预对临床试验招募和保留率的影响。主要分析显示PPI干预适度但显著提高招募几率(OR 1.16,95%CI 1.01-1.34),有疾病亲身经历者参与与招募改善显著相关(OR 3.14 vs 1.07;P=0.02)。保留率因研究不足结论不确定(OR 1.16,95%CI 0.33-4.14)。
要点
- PPI干预可能适度提高临床试验招募几率,尤其包含有疾病亲身经历者时效果更显著。
- PPI对保留率的影响因 eligible 研究太少而结论不确定。
- 需进一步研究PPI的最佳类型、成本效果及针对保留的干预。
核心结论
- PPI干预可能改善临床试验招募,尤其当有疾病亲身经历者参与时。
- PPI对保留率的影响尚不明确,需更多研究。
研究设计与样本
- 纳入定量评估PPI干预对比无干预或非PPI干预对招募和/或保留率影响的实验和观察性研究。
- 共纳入26项研究,其中19项符合招募荟萃分析,5项符合保留荟萃分析。
- 采用随机效应荟萃分析,主要分析仅纳入随机研究,次要分析加入非随机研究。
主要发现
- 主要分析中PPI干预适度但显著增加招募几率(OR 1.16,95%CI 1.01-1.34)。
- 干预中的非PPI成分可能对效应有贡献。
- 探索性亚组分析显示,有疾病亲身经历者参与与招募改善显著相关(OR 3.14 vs 1.07;P=0.02)。
- 保留率主要分析结果不确定(OR 1.16,95%CI 0.33-4.14)。
关键数值与推荐
- 招募主要分析OR 1.16(95%CI 1.01-1.34)。
- 有疾病亲身经历者参与亚组OR 3.14 vs 1.07(P=0.02)。
- 保留主要分析OR 1.16(95%CI 0.33-4.14)。
临床怎么用
- 在临床试验中考虑纳入PPI干预以改善招募。
- 优先纳入有疾病亲身经历者参与PPI。
- PPI对保留的效果需进一步研究确认。
局限性
- 保留率分析因 eligible 研究太少而结论不确定。
- 非PPI成分可能混杂招募效应。
- 需进一步研究PPI的最佳类型、背景、成本效果及早期设计阶段影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of patient and public involvement (PPI) on rates of enrolment and retention in clinical trials and explore how this varies with the context and nature of PPI. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Ten electronic databases, including Medline, INVOLVE Evidence Library, and clinical trial registries. ELIGIBILITY CRITERIA: Experimental and observational studies quantitatively evaluating the impact of a PPI intervention, compared with no intervention or non-PPI intervention(s), on participant enrolment and/or retention rates in a clinical trial or trials. PPI interventions could include additional non-PPI components inseparable from the PPI (for example, other stakeholder involvement). DATA EXTRACTION AND ANALYSIS: Two independent reviewers extracted data on enrolment and retention rates, as well as on the context and characteristics of PPI intervention, and assessed risk of bias. Random effects meta-analyses were used to determine the average effect of PPI interventions on enrolment and retention in clinical trials: main analysis including randomised studies only, secondary analysis adding non-randomised studies, and several exploratory subgroup and sensitivity analyses. RESULTS: 26 studies were included in the review; 19 were eligible for enrolment meta-analysis and five for retention meta-analysis. Various PPI interventions were identified with different degrees of involvement, different numbers and types of people involved, and input at different stages of the trial process. On average, PPI interventions modestly but significantly increased the odds of participant enrolment in the main analysis (odds ratio 1.16, 95% confidence interval and prediction interval 1.01 to 1.34). Non-PPI components of interventions may have contributed to this effect. In exploratory subgroup analyses, the involvement of people with lived experience of the condition under study was significantly associated with improved enrolment (odds ratio 3.14 v 1.07; P=0.02). The findings for retention were inconclusive owing to the paucity of eligible studies (odds ratio 1.16, 95% confidence interval 0.33 to 4.14), for main analysis). CONCLUSIONS: These findings add weight to the case for PPI in clinical trials by indicating that it is likely to improve enrolment of participants, especially if it includes people with lived experience of the health condition under study. Further research is needed to assess which types of PPI work best in particular contexts, the cost effectiveness of PPI, the impact of PPI at earlier stages of trial design, and the impact of PPI interventions specifically targeting retention. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016043808.
引用
- Crocker JC, Ricci-Cabello I, Parker A, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018. PMID: 30487232. doi:10.1136/bmj.k4738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。